Saturday, January 15, 2005
A few articles online that I've run across:
http://www.cms.hhs.gov/quality/hospital/SummaryOfMeeting.pdf This article is about a study which shows that ARBs, a/k/a AIIBs, angiotensin-II blockers, a/k/a "sartans" do as much good for patients with heart failure or left ventricular systolic disfunction as the older ACE inhibitors do. The protocols for standard treatment of heart failure will be rewritten to say ACEI or ARBs should be prescribed for HF patients. This is a report from a medical meeting, so it's fairly technical.
http://www.heartcenteronline.com/myheartdr/home/research-detail.cfm?reutersid=4985&nl=2
C-reactive protein, statin therapy measured in heart disease
Jan 05 (HeartCenterOnline) - A pair of studies appears to have confirmed the importance of C-reactive protein in coronary heart disease.
http://www.heartcenteronline.com/myheartdr/home/research-detail.cfm?reutersid=4977&nl=3
Dual pacemakers worth the cost, U.S. study finds
Jan 04 (Reuters) - Pricey pacemakers that regulate the heart's upper and lower chambers separately are worth the extra cost because they help keep patients out of the hospital, US researchers reported on Monday.
The fancier dual-chamber models cost about $3,000 more than single-chamber devices and do not help patients live any longer on average, but still save money over time, the government-funded study found.
"The dual-chamber devices significantly reduced the rates of atrial fibrillation and heart failure hospitalizations, which over the long term results in a highly favorable cost-effectiveness ratio," said Dr. David Cohen of Harvard Medical School in Boston, who led the study.
http://www.heartcenteronline.com/myheartdr/home/research-detail.cfm?reutersid=4981&nl=4
Eye disease predicts heart failure
Jan 05 (Reuters Health) - A common type of disease that involves the back of the eye, known as retinopathy, is a risk factor for heart failure, even in the absence of preexisting heart disease, high blood pressure or diabetes, according to a new report.
For the complete text of each article, click on the links given.
http://www.cms.hhs.gov/quality/hospital/SummaryOfMeeting.pdf This article is about a study which shows that ARBs, a/k/a AIIBs, angiotensin-II blockers, a/k/a "sartans" do as much good for patients with heart failure or left ventricular systolic disfunction as the older ACE inhibitors do. The protocols for standard treatment of heart failure will be rewritten to say ACEI or ARBs should be prescribed for HF patients. This is a report from a medical meeting, so it's fairly technical.
http://www.heartcenteronline.com/myheartdr/home/research-detail.cfm?reutersid=4985&nl=2
C-reactive protein, statin therapy measured in heart disease
Jan 05 (HeartCenterOnline) - A pair of studies appears to have confirmed the importance of C-reactive protein in coronary heart disease.
http://www.heartcenteronline.com/myheartdr/home/research-detail.cfm?reutersid=4977&nl=3
Dual pacemakers worth the cost, U.S. study finds
Jan 04 (Reuters) - Pricey pacemakers that regulate the heart's upper and lower chambers separately are worth the extra cost because they help keep patients out of the hospital, US researchers reported on Monday.
The fancier dual-chamber models cost about $3,000 more than single-chamber devices and do not help patients live any longer on average, but still save money over time, the government-funded study found.
"The dual-chamber devices significantly reduced the rates of atrial fibrillation and heart failure hospitalizations, which over the long term results in a highly favorable cost-effectiveness ratio," said Dr. David Cohen of Harvard Medical School in Boston, who led the study.
http://www.heartcenteronline.com/myheartdr/home/research-detail.cfm?reutersid=4981&nl=4
Eye disease predicts heart failure
Jan 05 (Reuters Health) - A common type of disease that involves the back of the eye, known as retinopathy, is a risk factor for heart failure, even in the absence of preexisting heart disease, high blood pressure or diabetes, according to a new report.
For the complete text of each article, click on the links given.
